Most Recent

image: Drugmakers Question FDA's Integrity

Drugmakers Question FDA's Integrity

By | September 26, 2012

Pharmaceutical and biotech companies ask the US Food and Drug Administration to ensure the independence of a third-party audit of its new drug program.

0 Comments

image: The Golden Goose Is Awarded

The Golden Goose Is Awarded

By | September 12, 2012

Researchers are given a prize for high-impact science that began with an unusual or seemingly frivolous study.

0 Comments

image: Lasker Winners Announced

Lasker Winners Announced

By | September 10, 2012

This year’s prizes are awarded for advances in liver transplantation, cell biology, and leadership in biomedical science.

0 Comments

image: Rethinking Herbal Medicine

Rethinking Herbal Medicine

By | September 10, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

21 Comments

image: Do it Yourself TB Test

Do it Yourself TB Test

By | September 5, 2012

With a cardboard box, a light source, and some filters, roadside clinics can accurately test for tuberculosis.

2 Comments

image: A Story Biological

A Story Biological

By | September 1, 2012

Using scientific information as narrative can be a powerful way to communicate.

0 Comments

image: Enter the Third Dimension

Enter the Third Dimension

By | September 1, 2012

Cell culture goes 3-D with devices that better mimic in vivo conditions.

2 Comments

image: Of Frogs and Embryos

Of Frogs and Embryos

By | September 1, 2012

Associate Professor in Molecular Cell & Developmental Biology at the University of Texas at Austin, John Wallingford, makes his living using cutting-edge microscopic techniques to watch developmental events unfold in real time.

4 Comments

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.

0 Comments

image: FDA to Debate Starch Treatment

FDA to Debate Starch Treatment

By | August 31, 2012

The US Food and Drug Administration will consider whether or not to stop the use of intravenous starch solutions to replace lost blood.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS